47 | ruxolitinibIBA
07/2022
-
03/2012 |
22 | Hydroxyurea (Hydrea)FDA LinkGeneric
12/2022
-
08/2010 |
13 | Janus Kinase InhibitorsIBA
07/2022
-
12/2013 |
12 | Janus KinasesIBA
07/2022
-
11/2010 |
12 | Hemoglobins (Hemoglobin)IBA
12/2021
-
05/2002 |
10 | Pharmaceutical PreparationsIBA
12/2021
-
05/2002 |
10 | CalreticulinIBA
01/2019
-
03/2014 |
9 | Janus Kinase 2IBA
05/2021
-
08/2007 |
8 | fedratinibIBA
01/2022
-
08/2015 |
8 | Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019
-
01/2007 |
7 | CytokinesIBA
01/2020
-
12/2004 |
7 | Syntex adjuvant formulationIBA
12/2017
-
07/2011 |
6 | MicroRNAs (MicroRNA)IBA
01/2019
-
11/2007 |
5 | InterferonsIBA
12/2022
-
01/2017 |
5 | Proteins (Proteins, Gene)FDA Link
01/2021
-
11/2009 |
4 | Janus Kinase 1IBA
10/2021
-
12/2012 |
4 | givinostatIBA
01/2021
-
08/2010 |
4 | Thrombopoietin (c-mpl Ligand)IBA
01/2020
-
06/2004 |
4 | EverolimusFDA Link
11/2017
-
08/2011 |
4 | Immunologic Factors (Immunomodulators)IBA
01/2017
-
02/2011 |
4 | Reticulin (Reticular Fiber)IBA
04/2014
-
05/2009 |
3 | imetelstatIBA
07/2022
-
10/2021 |
3 | Biomarkers (Surrogate Marker)IBA
10/2021
-
02/2011 |
3 | Phosphotransferases (Kinase)IBA
10/2021
-
12/2013 |
3 | AnticoagulantsIBA
10/2021
-
03/2008 |
3 | pomalidomideIBA
01/2021
-
01/2011 |
3 | Histone Deacetylase InhibitorsIBA
01/2020
-
08/2010 |
3 | Biological ProductsIBA
10/2018
-
12/2010 |
3 | anagrelide (Agrylin)FDA LinkGeneric
01/2017
-
12/2011 |
3 | ErythropoietinFDA Link
04/2014
-
06/2011 |
3 | Imatinib Mesylate (Gleevec)FDA Link
11/2010
-
12/2009 |
2 | avapritinibIBA
11/2022
-
12/2021 |
2 | Telomerase (Telomerase Reverse Transcriptase)IBA
07/2022
-
10/2021 |
2 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
01/2022
-
05/2017 |
2 | Interleukin-3 (Interleukin 3)IBA
01/2020
-
11/2009 |
2 | Thrombopoietin ReceptorsIBA
01/2020
-
12/2010 |
2 | Dihydrotachysterol (AT 10)IBA
01/2019
-
08/2011 |
2 | RNA (Ribonucleic Acid)IBA
01/2015
-
03/2012 |
2 | Messenger RNA (mRNA)IBA
09/2014
-
11/2009 |
2 | TOR Serine-Threonine KinasesIBA
01/2013
-
07/2011 |
2 | bepafantIBA
10/2009
-
05/2002 |
1 | Interleukin-1 Receptor-Associated KinasesIBA
01/2022 |
1 | RG7388IBA
01/2022 |
1 | Busulfan (Busulfex)FDA Link
12/2021 |
1 | VaccinesIBA
12/2021 |
1 | daratumumabIBA
11/2021 |
1 | Cytokine Receptors (Cytokine Receptor)IBA
06/2021 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2021 |
1 | Lenalidomide (CC 5013)FDA Link
01/2021 |
1 | ChromatinIBA
01/2021 |
1 | Oxygen (Dioxygen)IBA
01/2021 |
1 | Azacitidine (5 Azacytidine)FDA Link
01/2021 |
1 | DecitabineFDA Link
01/2021 |
1 | Interleukin-13IBA
01/2021 |